Skip to content
DraconiticResearch
Search Sources API
181,686 studies31 sourcesUpdated 7 min ago
Peer-reviewedLicence not statedDiabetes Obesity and Metabolism

Safety Profile of Tirzepatide in Real‐World Clinical Practice: A Pharmacovigilance Study Using the FAERS Database

  • Xinghua Guo1
  • Jiahua Zhang2
  • Qisen Li1
  • Zhiqiang Ye1
  • Shengyong Yuan1
  1. 1Department of Pharmacy Maoming People's Hospital Maoming China
  2. 2School of Pharmaceutical Sciences Southern Medical University Guangzhou China
Open at sourcePDFDOICite

Related

  1. Real-world safety profile of finerenone in patients with type 2 diabetes and chronic kidney disease: a multi-database pharmacovigilance analysis of the FAERS and JADER systems
    Dan Zhang, Yun Zhao, Haiting Chen +1
    Frontiers in clinical diabetes and healthcarePeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
  2. The Real-World Safety Profile of Haloperidol: A Comprehensive Pharmacovigilance Analysis Using the Large-Scale FAERS Database.
    Nengping Luo, Lu Xiao, Ying Liu +1
    CNS neuroscience & therapeuticsPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  3. Post-Initiation Care Patterns and Weight Loss With Semaglutide and Tirzepatide for Obesity in Clinical Practice
    H. Yang, C. Kim, J. S. Ross +11
    medRxivPreprintCC BYFull textCardiovascular medicinemedRxiv
  4. Drugs associated with systemic sclerosis: An updated list of suspected drugs using the WHO pharmacovigilance database
    Anaël Dumont, Charles Dolladille, Hubert de Boysson +4
    Autoimmunity ReviewsPeer-reviewedLicence not stated4 citedPharmacology & toxicologyHAL
  5. Adverse drug events associated with hydroxychloroquine : A real-world pharmacovigilance study from 2004 to 2024 using the FAERS database
    Shiwei Yuan, Zhen Li, Yongchang Yuan +8
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{guo2026safety,
  title = {{Safety Profile of Tirzepatide in Real‐World Clinical Practice: A Pharmacovigilance Study Using the FAERS Database}},
  author = {Xinghua Guo and Jiahua Zhang and Qisen Li and Zhiqiang Ye and Shengyong Yuan},
  journal = {Diabetes Obesity and Metabolism},
  year = {2026},
  month = jul,
  doi = {10.1111/dom.71025},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC13538822/},
}
RIS
TY  - JOUR
TI  - Safety Profile of Tirzepatide in Real‐World Clinical Practice: A Pharmacovigilance Study Using the FAERS Database
AU  - Xinghua Guo
AU  - Jiahua Zhang
AU  - Qisen Li
AU  - Zhiqiang Ye
AU  - Shengyong Yuan
PY  - 2026
DA  - 2026/07/13
JO  - Diabetes Obesity and Metabolism
DO  - 10.1111/dom.71025
UR  - https://pmc.ncbi.nlm.nih.gov/articles/PMC13538822/
SN  - 1462-8902
SN  - 1463-1326
ER  -